By Tom Winnifrith | Monday 9 July 2018
Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
As you can see HERE, I have spent the morning loading a white van as boxes of my stuff heads out to the Greek Hovel which might just have a roof by the weekend! Yesterday i was in Manchester and braving its slums albeit with Brokerman Dan providing security was heroic. For that, if not for the planned 32 mile walk with Dan how about you give a tenner to Woodlarks HERE. On the podcast I cover Optibiotix (OPTI), another victim of Julie "lingerie on expenses" Meyer MBE on the phone, Stobart (STOB), FairFx (FFX), Mothercare (MTC) and - with not too much sniggering - the flop at me-too Viagra play N4 Pharma (N4P)